Tacatuzumab tetraxetan

Revision as of 20:22, 27 September 2011 by WikiBot (talk | contribs) (Protected "Tacatuzumab tetraxetan": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Drugbox-mab

WikiDoc Resources for Tacatuzumab tetraxetan

Articles

Most recent articles on Tacatuzumab tetraxetan

Most cited articles on Tacatuzumab tetraxetan

Review articles on Tacatuzumab tetraxetan

Articles on Tacatuzumab tetraxetan in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tacatuzumab tetraxetan

Images of Tacatuzumab tetraxetan

Photos of Tacatuzumab tetraxetan

Podcasts & MP3s on Tacatuzumab tetraxetan

Videos on Tacatuzumab tetraxetan

Evidence Based Medicine

Cochrane Collaboration on Tacatuzumab tetraxetan

Bandolier on Tacatuzumab tetraxetan

TRIP on Tacatuzumab tetraxetan

Clinical Trials

Ongoing Trials on Tacatuzumab tetraxetan at Clinical Trials.gov

Trial results on Tacatuzumab tetraxetan

Clinical Trials on Tacatuzumab tetraxetan at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tacatuzumab tetraxetan

NICE Guidance on Tacatuzumab tetraxetan

NHS PRODIGY Guidance

FDA on Tacatuzumab tetraxetan

CDC on Tacatuzumab tetraxetan

Books

Books on Tacatuzumab tetraxetan

News

Tacatuzumab tetraxetan in the news

Be alerted to news on Tacatuzumab tetraxetan

News trends on Tacatuzumab tetraxetan

Commentary

Blogs on Tacatuzumab tetraxetan

Definitions

Definitions of Tacatuzumab tetraxetan

Patient Resources / Community

Patient resources on Tacatuzumab tetraxetan

Discussion groups on Tacatuzumab tetraxetan

Patient Handouts on Tacatuzumab tetraxetan

Directions to Hospitals Treating Tacatuzumab tetraxetan

Risk calculators and risk factors for Tacatuzumab tetraxetan

Healthcare Provider Resources

Symptoms of Tacatuzumab tetraxetan

Causes & Risk Factors for Tacatuzumab tetraxetan

Diagnostic studies for Tacatuzumab tetraxetan

Treatment of Tacatuzumab tetraxetan

Continuing Medical Education (CME)

CME Programs on Tacatuzumab tetraxetan

International

Tacatuzumab tetraxetan en Espanol

Tacatuzumab tetraxetan en Francais

Business

Tacatuzumab tetraxetan in the Marketplace

Patents on Tacatuzumab tetraxetan

Experimental / Informatics

List of terms related to Tacatuzumab tetraxetan

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Tacatuzumab tetraxetan is a humanized monoclonal antibody used to treat cancer. Tacatuzumab has a chelator, tetraxetan. It has a radioisotope, yttrium-90Y.

Template:Humanizedmonoclonals Template:SIB Template:WH Template:WikiDoc Sources